Mark Bachleda L.'s most recent trade in Lyell Immunopharma Inc was a trade of 9,250 Option (right to buy) done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyell Immunopharma Inc | Mark L. Bachleda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 9,250 | 9,250 | - | - | Option (right to buy) | |
| Lyell Immunopharma Inc | Mark Bachleda L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 13,000 | 13,000 | - | - | Option (right to buy) |